Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma

NCT00003778 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

NIH

Sponsor class

Conditions

Ovarian Cancer
Sarcoma

Interventions

DRUG: dolastatin 10

Sponsor

National Cancer Institute (NCI)